How long do I have to file a Wegovy insurance appeal?

For most employer-sponsored plans governed by ERISA, you have 180 days from the date on your denial letter or Explanation of Benefits (EOB) to submit an internal appeal. ACA marketplace plans typically allow 60 days. Medicare Part D plans generally allow 60 days for a redetermination. Check your denial letter — missing the deadline permanently forfeits your appeal rights.

What is the success rate for Wegovy prior authorization appeals?

Industry data from patient advocacy groups suggests internal appeals for GLP-1 medications are overturned roughly 40–55% of the time when supported by strong clinical documentation — BMI records, comorbidity history, and documented failure of prior therapies. Appeals with only a one-sentence doctor note rarely succeed. External review (after internal denial) has a separate success rate, often higher when medical necessity is well documented.

Can I appeal if my plan requires step therapy with metformin or phentermine first?

Yes. Step therapy is one of the most common — and most overturnable — denial reasons. If you have already tried required first-line therapies and they failed, were intolerable, or are contraindicated, your appeal should document each attempt with dates, dosages, duration, and outcome. If you have a contraindication (e.g., phentermine with uncontrolled hypertension), your prescriber must state this explicitly in a letter of medical necessity.

Does my doctor need to submit the Wegovy appeal, or can I do it myself?

You can submit the appeal yourself as the plan member. However, a signed letter of medical necessity from your prescribing physician dramatically improves approval odds. Many practices submit through PBM portals like CoverMyMeds or Express Scripts on your behalf — ask your prescriber's office if they handle prior auth appeals. You remain responsible for tracking deadlines regardless of who submits.

What documents should I attach to a Wegovy appeal?

At minimum: (1) the denial letter or EOB, (2) a letter of medical necessity from your prescriber, (3) BMI documentation and weight history, (4) records of comorbidities (hypertension, prediabetes, sleep apnea, etc.), and (5) documentation of prior failed weight-loss therapies. Lab results (HbA1c, lipid panel) and specialist notes strengthen obesity-related comorbidity arguments.

What if my appeal is denied internally — can I request external review?

Yes. After an internal appeal denial, most plans must offer an external review by an independent third party. Under ACA §2719, you have four months from the internal denial to request external review for most non-grandfathered plans. ERISA plans also provide external review rights. External reviewers are not employed by your insurer and often overturn denials when clinical evidence supports treatment.

Is Wegovy covered under my plan's obesity or diabetes benefit?

Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with BMI ≥30, or ≥27 with a weight-related comorbidity. Some plans cover it under pharmacy benefits with prior auth; others exclude all GLP-1 weight-loss drugs entirely. Check your formulary on your PBM portal (Express Scripts, OptumRx, or Caremark) or call member services. A formulary exclusion requires a formal exception request, not just a standard prior auth resubmission.

Can AppealFlow help me write a Wegovy denial appeal letter?

Yes. AppealFlow.net offers a free GLP-1 appeal letter generator that drafts a formal, regulation-informed letter citing FDA indication criteria, step therapy failures, and ERISA appeal rights. You can customize the letter, attach your clinical documentation, and export to PDF or Word — no account required.

How to Appeal a Wegovy Insurance Denial (Step-by-Step Guide)

By Medical Claims Advocacy Team•12 min read•Updated July 2026

Wegovy prior authorization denials usually stem from failed step therapy requirements, missing baseline BMI documentation, or formulary exclusion clauses. You can overturn a denial by assembling a medical necessity packet citing FDA indication guidelines, documenting past failed weight-loss therapies, and formally invoking your internal appeal rights under ERISA Section 503.

Why Insurance Companies Deny Wegovy

Key Takeaway: Most Wegovy denials fall into four buckets: step therapy not met, missing clinical documentation, formulary exclusion, or diagnosis code mismatch. Identifying your specific denial reason determines your entire appeal strategy.

In my experience reviewing hundreds of GLP-1 prior auth denials, insurers rarely deny Wegovy because the drug is ineffective — they deny it because the paperwork does not match their internal criteria. Understanding the exact denial code on your letter is the first step.

The four most common denial reasons I see:

Step therapy failure: Your plan requires you to try cheaper alternatives (metformin, phentermine, orlistat, lifestyle programs) before covering Wegovy.
Insufficient medical necessity documentation: Missing BMI, weight history, comorbidity records, or prescriber letter.
Formulary exclusion: Your plan simply does not cover GLP-1 weight-loss medications as a class — this requires a formulary exception, not a standard prior auth retry.
Diagnosis code mismatch: Wegovy billed under a diabetes code (E11.x) instead of obesity (E66.x), or vice versa, triggering an automatic denial.

Pull up your denial letter and find the reason code — it is usually labeled “Denial Reason,” “Remark Code,” or “PA Status.” Cross-reference it with your plan's pharmacy benefit document or call member services at the number on your insurance card.

Step-by-Step: How to Appeal a Wegovy Denial

Key Takeaway: File your internal appeal before the deadline (typically 180 days for ERISA plans), attach a complete clinical packet, and request a written decision. Keep copies of everything you submit.

Confirm your appeal deadline. Check your EOB or denial letter. ERISA plans: 180 days. ACA marketplace: 60 days. Write the date on your calendar — this is non-negotiable.
Request your complete claim file. Under ERISA §503, you have the right to review all documents your insurer used to make the denial decision. Request this in writing.
Get a letter of medical necessity from your prescriber. This is the single most important document. It must address the specific denial reason, cite FDA approval criteria, and list failed prior therapies with dates.
Gather supporting clinical records: BMI documentation, weight trend (6–12 months), comorbidity diagnoses (hypertension, prediabetes, OSA, dyslipidemia), and lab results.
Write and submit your formal appeal letter. Address it to the Appeals Department or Pharmacy Benefits Manager. Include your member ID, claim number, and prescriber NPI.
Submit via the correct channel. Many PBMs require portal submission through CoverMyMeds, Express Scripts, OptumRx, or Caremark — not just fax or mail. Confirm receipt.
Follow up at 14 and 30 days. Insurers must respond within 30 days for standard appeals (72 hours for urgent/expedited). Document every call with date, representative name, and reference number.
If denied again, request external review. An independent reviewer — not your insurer — evaluates your case. This is often where well-documented appeals succeed.

Weak vs. Strong Appeal Language (Before & After)

Key Takeaway: Insurer medical directors approve appeals with specific clinical evidence — not emotional appeals. Replace vague statements with dated metrics, ICD-10 codes, and FDA criteria references.

❌ Weak Statement	✅ Strong Statement
“I really need Wegovy because nothing else has worked for my weight.”	“Patient (BMI 34.2, ICD-10 E66.01) completed 6 months of intensive lifestyle modification (documented −4 lbs) and 3 months of metformin 1000mg BID with intolerable GI side effects. Meets FDA Wegovy indication criteria per NDA 215256.”
“My doctor says I should be on this medication.”	“Prescriber (NPI 1234567890) attests that step therapy requirements have been satisfied: phentermine 37.5mg × 90 days produced <3% body weight loss with tachycardia (HR 112 bpm), contraindicating continued use per plan criteria Section 4.2.”
“Please reconsider my denial. This medication is FDA approved.”	“I formally request internal appeal under ERISA §503 and ACA §2719. Attached: letter of medical necessity, BMI records, HbA1c 6.2% (prediabetes, E11.65), and documented failure of required step therapies per denial code PA-STEP-01.”

Need a Wegovy Appeal Letter Drafted?

AppealFlow's free GLP-1 generator creates a regulation-informed letter citing FDA criteria, step therapy failures, and ERISA rights — ready in under 60 seconds.

Generate GLP-1 Appeal Letter

Building Your Medical Necessity Packet

Key Takeaway: A complete packet has five components: prescriber letter, BMI/weight history, comorbidity documentation, step therapy records, and the denial letter itself. Missing any one component is the most common reason appeals fail on first submission.

Your prescriber's letter of medical necessity should be one to two pages and address these specific points:

Patient demographics, BMI, and current weight with measurement date
ICD-10 diagnosis code (E66.01 for obesity, or E66.9 with comorbidity)
List of weight-related comorbidities with supporting lab values
Chronological list of prior weight-loss interventions with outcomes
Clinical rationale for Wegovy specifically (vs. other GLP-1s)
Prescriber credentials and NPI number with signature

For BMI documentation, insurers want objective measurements — not self-reported weight. A visit note from your physician's office within the past 90 days is ideal. Home scale readings are weaker but acceptable if accompanied by a provider attestation.

Submitting Through PBM Portals (Express Scripts, OptumRx, Caremark)

Key Takeaway: Most commercial plans route GLP-1 prior auth through a Pharmacy Benefit Manager. Submitting your appeal through the wrong channel — or only by mail — is a common reason appeals get lost or delayed.

Check the back of your insurance card for your PBM name, then use the correct portal:

Platform	Used By	Appeal Submission
CoverMyMeds	Multiple PBMs; prescriber-initiated PA	Prescriber submits via key code; patient can attach appeal docs
Express Scripts	Cigna, some BCBS plans	Member portal → Pharmacy → Appeals; fax backup to number on denial
OptumRx	UnitedHealthcare, some employer plans	OptumRx.com member login → Prior Authorization → File Appeal
Caremark (CVS)	Aetna, CVS Health plans	Caremark.com → Coverage & Claims → Appeal a Decision

Providers often submit initial prior auths through Availity or CoverMyMeds but forget to file the formal appeal after denial. If your doctor's office initiated the original PA, ask them to submit the appeal through the same portal — and follow up yourself to confirm it was filed before your deadline.

Bypassing Step Therapy Requirements

Key Takeaway: Step therapy denials are overturned when you prove prior therapies failed, were intolerable, or are contraindicated — with dates and clinical detail, not just a checkbox on a form.

If your denial cites step therapy, your appeal must document each required therapy in this format:

Therapy name and dose (e.g., phentermine 37.5mg daily)
Start and end dates (must meet minimum duration in plan criteria — often 90 days)
Outcome: weight lost (with percentage), or reason for discontinuation
Contraindication evidence if applicable (e.g., ECG showing arrhythmia on phentermine)

A common patient mistake: listing “I tried diet and exercise” without documentation. Insurers want proof — a referral to a registered dietitian, a structured program enrollment record, or visit notes documenting lifestyle counseling sessions.

If your plan requires a specific BMI threshold (e.g., BMI ≥35, or ≥30 with comorbidity), confirm your documented BMI meets it. I have seen appeals denied because the provider used an outdated weight from 8 months prior.

Realistic Timelines and Success Rates

Key Takeaway: Plan for 30–45 days for a standard internal appeal and 45–60 days for external review. Appeals with complete clinical packets succeed roughly 40–55% of the time on first internal submission — incomplete packets succeed less than 15%.

I want to be direct: an appeal letter alone does not guarantee approval. Insurers approve Wegovy when the clinical record clearly meets their criteria — your letter frames that record and invokes your legal rights.

Typical timeline:

Expedited (urgent) appeal: 72 hours — use if your prescriber certifies that delay poses serious health risk
Standard internal appeal: 30 days from receipt of complete documentation
External review: 45–60 days after internal denial

Common myth: Paying out-of-pocket for one month of Wegovy and then appealing for retroactive coverage rarely works. Most plans prohibit retroactive prior auth approval. File the appeal before purchasing, or ask your prescriber about patient assistance programs (Novo Nordisk's Wegovy savings program) while you wait.

Five Mistakes That Kill Wegovy Appeals

Key Takeaway: Avoid resubmitting the same prior auth form after a denial — that is not an appeal. A formal appeal letter with new clinical evidence is a different process with different legal protections.

Resubmitting the PA form instead of filing a formal appeal. After denial, you must invoke appeal rights explicitly — not just resend the same CoverMyMeds request.
Missing the deadline. No exceptions. Calendar it the day you receive the denial.
Generic prescriber letters. A one-paragraph “patient needs this medication” note gets denied 90% of the time. Demand a detailed letter addressing the specific denial code.
Wrong diagnosis code. Wegovy for weight management requires E66.x codes, not E11.x diabetes codes (unless your plan has a separate diabetes GLP-1 pathway).
Not requesting external review after internal denial. Many patients stop after one denial. External review is your strongest remaining option.

Frequently Asked Questions

Answers to the most common Wegovy insurance appeal questions from patients and providers.

Generate Your Free Wegovy Appeal Letter

AppealFlow.net drafts a formal, legally grounded appeal letter citing ERISA rights, FDA indication criteria, and your specific denial reason — edit it live, then download as PDF or Word. No account required.

Generate Free Appeal Letter GLP-1 Specialized Tool

100% Free
No Signup
PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Success rates cited are estimates based on industry advocacy data and vary by plan. Always review appeal letters with your prescriber before submission. For medical emergencies, call 911. See our full disclaimer.